 BASKING RIDGE, N.J., April 27, 2020 GLOBE NEWSWIRE -- electroCore, Inc. ECOR, a commercial-stage bioelectronic medicine company, today provided an update on ongoing nVNS COVID-19 initiatives. The company announced today that an investigator-initiated, randomized, controlled clinical trial of nVNS therapy has commenced enrolling COVID-19 patients in Spain. 